David K Choi

21PUBLICATIONS

17CO-AUTHORS

Cardiology (incl. cardiovascular diseases)Clinical pharmacology and therapeuticsAutoimmunityAllergyImmunology not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|Jun 09, 2026

Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients with Baseline Cardiovascular Risk.

|May 14, 2026

Evaluation of a pharmacist directed treat to target approach in patients with inflammatory bowel disease receiving upadacitinib or risankizumab.

|Aug 22, 2025

New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.

Russell Yanofsky, Benjamin D McDonald, Newsha Nikzad

|May 24, 2025

Incidence and Risk Factors for Development of Acne (JAKne) in Patients with Inflammatory Bowel Disease Treated With Upadacitinib.

David Choi, Amelia Kellar, Jeremy Klein

|Nov 07, 2024

Immediate Infusion Reaction to Intravenous Risankizumab-rzaa but Subsequent Tolerance to Subcutaneous Risankizumab-rzaa.

David Choi, Benjamin McDonald, David T Rubin

|Sep 03, 2024

Editorial: Finger in the dam-A clinical trial of long-acting somatostatin for high-output ostomies and fistulas.

David Choi, Shomron Ben-Horin

Pageof 4

Frequent Collaborators

David T Rubin

Shubha Bhat

Benjamin D McDonald

Costica Aloman

Maitri Patel

Xunjie Zhang

Cassie S Muran

Shomron Ben-Horin

Russell Yanofsky

Newsha Nikzad

Frequent Collaborators

David T Rubin

Shubha Bhat

Benjamin D McDonald

Costica Aloman